News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

AusBiotech Ltd. to Sign MOU With KoreaBIO to Support Biotechnology Collaboration Between Australia and Korea

10/29/2013 8:36:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

29 October 2013 -- The AusBiotech 2013 national conference will culminate on Friday (1 November) in the signing of a memorandum of understanding (MOU) between AusBiotech and the Korea Biotechnology Industry Organization (KoreaBIO).

The MOU is to recognise the key role that biotechnology plays in economic and social development, and the benefits of a strategic partnership between Australia and Korea. AusBiotech and KoreaBIO are the industry associations representing the biotechnology industries of Australia and Korea respectively.

To be signed by Dr Eun-Hee Bae, President of the Korea Biotechnology Industry Organization, and Dr Anna Lavelle, AusBiotech’s CEO, the MOU is to promote collaboration and cooperation in the area of biotechnology.

The objectives of the MOU are for both parties to: promote cooperation in biotechnology in areas of mutual interest, especially those relevant to economic and social development; promote the exchange of views in supporting the formulation and application of biotechnology policy by Government; and facilitate interaction between officials, scientists and technologists of Korea and Australia.

The MOU encourages and supports increased interaction between Korea and Australian biotechnology companies through access to visitor office facilities in Seoul and Melbourne to support members of KoreaBIO and AusBiotech when in Korea and Australia.

AusBiotech and KoreaBIO will seek to identify projects that can attract funding to support biotechnology collaboration between Korea and Australia.

A representative from the Strategic Planning Department of KoreaBIO, Ms You-me Choi, and members of AusBiotech Board, including Chairman, Dr Deborah Rathjen, will be present at the MOU signing ceremony, which will be held during the AusBiotech 2013 national conference in Brisbane.

The ceremony will take place at 1.00pm in the Arbour Boardroom of the Brisbane Convention and Exhibition Centre, on Friday 1 November 2013.

To attend or for further media information and interviews, please contact: Lorraine Chiroiu, AusBiotech’s Communications Manager, E: M: +61 (0) 429 801 118

For further information regarding the signing ceremony, please contact: Hayley Laing, AusBiotech, Investment Program Manager at

About AusBiotech and AusBiotech Investment

AusBiotech is Australia's biotechnology industry organisation working on behalf of over 3,000 members in the areas of human health, medical devices, food technology, agriculture, environmental and industrial biotechnology, for more than 25 years.

AusBiotech is dedicated to the development, growth and prosperity of the Australian biotechnology industry, by providing initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for members nationally and around the world.

AusBiotech Investment offers a comprehensive series of national and international investor events as a global platform for Australian life sciences companies to showcase their company’s offering for partnership and investment.

About KoreaBIO

The Korea Biotechnology Industry Organization was launched in November 2008, bringing together the Bioindustry Association of Korea (BAK), Korea Bio Venture Association and the Korea Biotechnology Research Association that each represented different segments of the biotechnology industry.

KoreaBIO seeks to strengthen cooperation among the government, bio-businesses and pharmaceutical companies to create new models for future growth. It also aims to facilitate communication between the government and business and to connect overseas industries, organisations and investors with Korea. Website:

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus